Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients

ClinicalTrials.gov ID: NCT01320202

Public ClinicalTrials.gov record NCT01320202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Phase III Study of Dialysate Containing Soluble Ferric Pyrophosphate (SFP) in Chronic Kidney Disease Patients Receiving Hemodialysis: The Continuous Replacement Using Iron Soluble Equivalents (CRUISE 1) Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to confirm the safety and efficacy of Soluble Ferric Pyrophosphate (SFP) dialysate solution in maintaining iron delivery for erythropoiesis in anemic adult patients with chronic kidney disease (CKD) receiving hemodialysis. Efficacy will be measured primarily by the change from baseline in hemoglobin (Hgb).

Study identification

NCT ID
NCT01320202
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
305 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2011 (Type not available)
Primary completion
May 2013 (Actual)
Completion
Nov 2013 (Actual)
Last update posted
Apr 26, 2017

2011 – 2013

United States locations

U.S. sites
45
U.S. states
16
U.S. cities
40
Facility City State ZIP Site status
Not listed Bakersfield California 93308 —
Investigative Site Chula Vista California 91910 —
Not listed Cudahy California 90201 —
Not listed Downey California 90240 —
Not listed Encino California 91316 —
Not listed Los Angeles California 90022 —
Not listed Los Angeles California 90033 —
Not listed Los Angeles California 90057 —
Not listed Los Angeles California 90404 —
Not listed National City California 91950 —
Not listed Northridge California 91324 —
Not listed Ontario California 91764 —
Not listed Panorama City California 91402 —
Not listed Riverside California 92505 —
Not listed San Dimas California 91773 —
Not listed Simi Valley California 93065 —
Not listed West Covina California 91792 —
Not listed Yuba City California 95991 —
Investigative Site Waterbury Connecticut 06708 —
Not listed Waterbury Connecticut 06708 —
Not listed Coral Springs Florida 33071 —
Not listed Miami Florida 33150 —
Investigative Site Augusta Georgia 30901 —
Not listed Chicago Illinois 60617 —
Not listed Michigan City Indiana 46360 —
Not listed Detroit Michigan 48202 —
Not listed Las Vegas Nevada 89102 —
Investigative Site Mineola New York 11501 —
Investigative Site Ridgewood New York 11385 —
Not listed Rosedale New York 11422 —
Not listed Yonkers New York 10704 —
Not listed Asheville North Carolina 28801 —
Not listed Durham North Carolina 27704 —
Not listed Winston-Salem North Carolina 27105 —
Not listed Cincinnati Ohio 45206 —
Not listed Toledo Ohio 43613 —
Not listed Sumter South Carolina 29150 —
Not listed Chattanooga Tennessee 37404 —
Not listed Arlington Texas 76011 —
Not listed Fort Worth Texas 76164 —
Investigative Site Houston Texas 77004 —
Not listed Houston Texas 77081 —
Not listed San Antonio Texas 78207 —
Not listed Fairfax Virginia 22030 —
Not listed Shorewood Wisconsin 53211 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01320202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2017 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01320202 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →